RxDoctor Payments Data

Sandra Garcia

Foot Surgery · Bronx, NYNPI 1992707665

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,483 of the $6,490 with a category attached, or 84.5%. 24 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 24.0% of the total. Reporting peaked in 2022 at $2,246 and has fallen 54.4% since, to $1,025 in 2025. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,490in general payments, 2019–2025

Across 149 payments — averaging $43.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$2K
  • Tactile Systems Technology Inc$1K
  • Paratek Pharmaceuticals, Inc.$933
  • Amgen$918
  • Smith+Nephew$502
  • Nevro Corp.$173
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$1,00816%
  • Food & beverage$5,48384%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,490 in reported general payments places this provider in the 90th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$10,319
Medicare patients
44
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diflorasone Diacetate20$16,642
Doxepin Hcl95$12,483
Naftifine Hcl22$12,244
Ketoconazole81$5,124
Fluocinonide49$3,972
Diclofenac Sodium ErDiclofenac Sodium34$2,834
Naproxen Sodium15$2,108
Ciclopirox27$1,495
Fluconazole11$1,320
Clotrimazole38$1,202
Ammonium Lactate23$340
Mupirocin32$194
Nabumetone20$100
Gabapentin26$54
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$44

Paid to pharmacies, not to this prescriber.

Other foot surgery in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →